2025年7月9日，法国左心室辅助装置（LVAD）开发商 CorWave 宣布，其自主研发的 基于独特波浪膜 技术的 CorWave LVAD 成功在澳大利亚完成全球首例人体植入手术。 此次手术于悉尼圣文森特医院完成，标志着可持续机械循环支持技术迈出具有里程碑意义的一步。 近日，一 位患有晚期心力衰竭接 受了 CorWave LVAD的 全球首例植入 ， 目前 手术已顺利完成，并达 到 30天无与设备相关并发症生存的主要终点 。目前该患者已康复出院，并表示"感觉比手术前好多了"， 不再感到明显的疲劳或呼吸困难。医疗团队仍在持续监测设备的良好运行情况。 目前在美国市场， 雅培（ Abbott） 是唯一的LVAD供应商，其 HeartMate 3 设备被广泛应用。 而CorWave的创新型心脏泵系统则采用了公司独创的 波浪膜驱动技术 ， 灵感源自水生动物的游动机制 ，意在实现对心血管系统生理平衡的保护。 与传统旋转泵不同（如 HeartMate系列持续固定流速），CorWave的设备 可根据患者状态自动调节血 流，实现动态响应 。在患者静息或活动状态下，该系统可同步心跳节律运作，保持血管的搏动效应，有助 于维持心 ...

Group 1 - The article discusses a closed-door exchange meeting aimed at helping medical device companies understand capital medical innovation policies and promote the deep integration of quality products with clinical scenarios [1] - The meeting is scheduled for July 17 and is exclusively for CEOs or core executives of medical device companies from regions outside Beijing [1] - Specific details regarding the meeting location and agenda will be provided after registration confirmation [1] Group 2 - The article outlines a series of upcoming global medical technology conferences, including the second Global Medical Technology Conference on July 17, 2025, and the third Global Surgical Robot Conference from September 3-5, 2025 [2] - Relevant government officials will introduce support policies and implementation paths during these events [2] - Key departments such as the Health Commission and Medical Insurance Bureau will explain market access and medical insurance payment processes [2]

以下文章来源于桡通心安 ，作者angiocare 桡通心安 . 上海安通医疗科技有限公司 本次手术由心内科主任Michele Capasso教授领衔，联合Geppina Eusebio博士、Emanuele De Vita博士 及 Giuseppe Bottiglieri博士 组成的心脏介入团队共同完 成。 Iberis铂睿时系统的核心优势有四： 这些优势让系统具备 创伤小、恢复快 的特点，使日间手术成为可能，进一步惠及患者预后与临床实践。 近日，意大利埃博利市 Maria SS Addolorata医院 心内科团队在 Biosensors International Group 与 安通医疗 的联合技术支持下，成功实施 意大利南部首例 基 于 Iberis铂睿时系统 的 RDN术 ，同时也是意大利 第二家 开展该技术的中心。该突破标志着Iberis铂睿时系统在欧洲的临床应用再增重要里程碑。 此次Iberis铂睿时RDN手术的成功，为区域内难治性高血压患者提供了新的治疗选择。医院计划 将本次手术的影像资料及技术细节纳入基层医师继续教育项目体系 ，以推动技术规范化推广与临床应用标准化，为区域内RDN技术的落地筑 ...

Core Viewpoint - The article discusses the recent developments in the Shanghai Stock Exchange (SSE) regarding the listing of companies under the Sci-Tech Innovation Board, particularly focusing on the upcoming IPO of Beixin Life, which is the second company to adopt the fifth set of listing standards in 2025 [1][3]. Group 1: Company Overview - Beixin Life is a medical device company specializing in innovative diagnostic equipment for cardiovascular diseases, with a focus on the development, production, and sales of its products [3]. - The company meets the listing criteria under the Sci-Tech Innovation Board, with an expected market value of no less than 4 billion yuan and has achieved significant milestones in its product development [3]. Group 2: Product and Market Position - The core products of Beixin Life include the intravascular ultrasound (IVUS) diagnostic system and the fractional flow reserve (FFR) measurement system, making it the first domestic company to offer a combination of these technologies [4]. - The FFR system captured a 30.6% market share in China shortly after its launch in 2020, indicating strong market acceptance and demand for its products [4]. Group 3: Financial Performance - Beixin Life reported net losses of 179 million yuan, 164 million yuan, and 63 million yuan for the years 2022 to 2024, respectively, with a cumulative undistributed profit of -736 million yuan as of the end of 2024 [4]. - The ongoing losses are attributed to a small revenue scale that cannot cover operational costs, particularly high R&D and sales expenses [4]. Group 4: Regulatory Environment - The SSE has recently implemented reforms to the Sci-Tech Innovation Board, allowing unprofitable companies to enter the growth tier without additional listing hurdles, which is significant for companies like Beixin Life [2][6]. - The new rules also include a special identifier "U" for stocks in the growth tier, helping investors distinguish between new and existing stocks in this category [7]. Group 5: Industry Context - Since the establishment of the Sci-Tech Innovation Board in 2019, 54 unprofitable companies have successfully listed, with 22 of them achieving profitability post-listing [6]. - The total revenue generated by these companies in 2024 reached 174.48 billion yuan, showcasing the potential for growth and recovery in the sector [6].

Market Performance - The FTSE China A50 Index components showed strong performance in the power, coal, and oil sectors, while the banking and liquor sectors experienced mixed results [1] - Notable market capitalization figures include China Petroleum at 16,252.26 billion, China Shenhua at 7,434.80 billion, and Kweichow Moutai at 1,788.32 billion [3][4] Sector Highlights - **Power Sector**: Strong performance noted, with significant trading volumes [1] - **Coal Sector**: China Shenhua's stock increased by 0.62 (+1.68%) with a market cap of 7,434.80 billion [3] - **Oil Sector**: China Petroleum's stock rose by 0.06 (+1.05%) with a market cap of 16,252.26 billion [3] - **Banking Sector**: Mixed results with China Everbright Bank showing a slight increase of 0.05 (+1.15%) [3] - **Liquor Sector**: Kweichow Moutai decreased by 3.40 (-0.24%) while other brands showed slight increases [3] Trading Volumes - Significant trading volumes were observed in various sectors, with the power sector leading [1] - China Petroleum had a trading volume of 7.29 billion, while China Shenhua had 55.02 billion [3] Company Specifics - **China Ping An**: Market cap of 3,781.15 billion with a trading volume of 9.71 billion, showing a slight decrease of 0.16 (-0.42%) [3] - **Ningde Times**: Market cap of 3,453.66 billion with a trading volume of 21.43 billion, decreased by 0.25 (-0.87%) [4] - **Kweichow Moutai**: Market cap of 1,788.32 billion with a trading volume of 39.62 billion, decreased by 3.40 (-0.24%) [3]

Core Insights - The Suzhou Industrial Park aims to become a "world-class high-tech park" by actively attracting international talent and creating a globally competitive talent development ecosystem [1][2] - As of the end of 2024, the park has gathered over 15,000 international talents, ranking first in Suzhou [1] - The park has established a comprehensive service system for international talents, including the Yangcheng International Talent Port and various service centers [2] Talent Attraction and Support - The Yangcheng International Talent Port focuses on five service functions: attraction, settlement, innovation, networking, and living [2] - The park has attracted 78 academic teams and over 6,700 high-level talents, with more than 3,800 leading talents [2] - The park has implemented 19 facilitation measures for foreign talents, including a single-window system for work and residence permits [3] Innovation and Development - The park has introduced innovative companies like Xueji Biotechnology, which focuses on platelet regeneration technology [4] - A new talent evaluation system has been established to align international qualifications with local standards, particularly in the biomedical field [4][5] Open Ecosystem - The park has launched initiatives to enhance the living environment for international talents, including the establishment of foreign-invested medical institutions [6] - The iDream talent platform and the "SIP Talent Worry-Free" WeChat mini-program facilitate efficient connections between international talents and local opportunities [6] - The influx of international talents enriches the local culture and enhances the city's attractiveness, positioning the park at the forefront of the global innovation chain [6]

Group 1 - The 2024 China-Africa Private Economy Cooperation Forum was held in Shenzhen, highlighting the city's role in international economic collaboration [2] - The establishment of the Global Drone Export Center in Shenzhen aims to support Chinese drone and AI product companies in accessing international markets [4] - Shenzhen is positioning itself as a global investment hub, with significant foreign investments from companies like Dassault Systems and GE Healthcare [4][5] Group 2 - Shenzhen has implemented 27 typical cases to enhance its international trade environment, focusing on facilitating foreign investment and improving business operations [5] - The city aims to attract over 50 billion yuan in foreign investment in 2025, expanding openness in various sectors including telecommunications and healthcare [6] - Shenzhen's initiatives include the "Qianhai Outbound E-Station" service platform, which consolidates various outbound services for enterprises, enhancing their international operations [8] Group 3 - Shenzhen is developing a high-level international trade hub to facilitate exports and enhance market access for local businesses [9] - The city has launched smart customs declaration features and expanded its international air and sea routes to improve logistics and trade efficiency [9][10] - In 2024, Shenzhen's foreign trade import and export volume reached 4.5 trillion yuan, marking a significant achievement in its trade performance [10]

Core Viewpoint - The "anti-involution" research trend is gaining momentum in the A-share market, with expectations that it may become the main theme for the next market phase, benefiting various sectors such as lithium batteries, photovoltaics, coal, steel, chemicals, energy, and construction materials [2][3][4]. Group 1: Research and Analysis - In the past week, a total of 176 research reports on the "anti-involution" theme were published by institutions, covering multiple industries including strategy, macroeconomics, steel, fossil energy, electrical equipment, building materials, non-ferrous metals, chemicals, and aquaculture [2]. - The "anti-involution" theme has become a focal point in analyst roadshows, with 79 related events held in the past week, indicating a strong institutional interest [2]. - Analysts believe that the current round of "anti-involution" has a higher standing, broader coverage, and stronger synergy, with potential implications for the market's next phase [3]. Group 2: Policy and Market Implications - The Central Financial Committee's recent meeting emphasized the need to promote a unified national market and address issues of low-price competition, which has led to increased attention on "anti-involution" in the capital market [3]. - The "anti-involution" policy is expected to unfold in three stages: policy expectations, price increases, and demand expansion, with a focus on sectors that may experience a turnaround [4]. Group 3: Beneficiary Industries - Key sectors expected to benefit from the "anti-involution" policies include: - Midstream and downstream manufacturing such as lithium batteries, photovoltaics, wind power, passenger vehicles, paper, and medical devices - Service and consumer sectors like food processing, express delivery, and small appliances - Resource materials including steel, cement/glass, consumer building materials, chemical fibers/agricultural chemicals, and energy metals - Real estate-related sectors such as kitchen appliances and home furnishings [5][6]. - The steel industry is highlighted for its potential bottom reversal, with supply-side reforms and improved profitability expected [8]. Group 4: Sector-Specific Insights - The photovoltaic industry is entering a high-quality development phase, with significant stock price increases observed in related sectors [9]. - Analysts suggest that the photovoltaic sector's recovery will depend on effective supply-side reforms and the establishment of a long-term mechanism for eliminating outdated capacity [9]. - Recent downgrades in specific photovoltaic stocks indicate a cautious outlook despite the overall positive sentiment in the sector [10].

值得一提的是，近年来北芯生命持续加大研发投入，搭建了微纳器件、介入导管、高性能医疗硬件及算 法软件四大技术平台，覆盖从核心传感器封装、导管加工到图像分析算法全链条能力，是国内唯一掌握 60MHz高频微型超声换能器与微型MEMS压力传感器完整设计及封装技术的企业。 2025年，公司推出首个国产冠脉功能学一体化解决方案、国产首款外周IVUS导管，并在电生理领域完 成脉冲电场消融（PFA）"single-shot"术式的关键突破，研究成果入选2025年欧洲心脏病学会大会突破 性临床研究专场。截至目前，公司累计申请专利超360项，已获得授权180余项，其中发明专利80余项、 PCT国际专利申请14项。 本报讯 （记者王镜茹）7月18日，上交所上市委将审议深圳北芯生命科技股份有限公司（以下简称"北 芯生命"）科创板IPO申请。据悉，北芯生命成立于2015年，是一家专注于心血管精准介入领域的创新 医疗（002173）器械企业，致力于通过高性能有源介入设备，为冠心病、外周血管疾病、房颤等重大疾 病提供智能化精准介入解决方案。 公司深耕冠脉功能学与影像学两大领域，自主研发突破多项"卡脖子"技术，先后推出中国首个自主研发 获批 ...

Group 1: Market Overview - The FTSE China A50 Index components showed a strong performance in the banking sector, with significant gains across various industries including power, coal, and oil, while the securities and consumer electronics sectors experienced declines [1][6]. Group 2: Sector Performance - The banking sector saw a rise in stock prices, with notable increases in major banks such as China Pacific Insurance and China Ping An, which had market capitalizations of 378.56 billion and 1,053.46 billion respectively [3]. - The power, coal, and oil sectors also performed well, with China Petroleum and China Shenhua Energy showing positive stock movements [4]. - Conversely, the securities sector, including firms like CITIC Securities, faced a decline, with a drop of 0.73% in stock price [4]. - The semiconductor industry had mixed results, with North China Innovation experiencing a decrease of 1.85%, while Cambrian Technology saw an increase of 2.35% [3][4]. Group 3: Notable Companies - Major companies in the liquor industry, such as Kweichow Moutai and Wuliangye, reported market capitalizations of 1,788.34 billion and 483.65 billion respectively, with Kweichow Moutai's stock price showing a slight decline of 0.24% [3]. - In the automotive sector, BYD's stock price increased by 0.31%, while other companies like SAIC Motor faced a decline [4]. - The technology sector, represented by companies like Industrial Fulian and Luxshare Precision, showed a downward trend, with stock prices decreasing by 0.69% and 0.65% respectively [4].